Report Highlights
Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide
Juvenile Macular Degeneration Pipeline Review, H1 2017, provides
comprehensive information on the therapeutics under development for
Juvenile Macular Degeneration (Ophthalmology), complete with analysis by
stage of development, drug target, mechanism of action (MoA), route of
administration (RoA) and molecule type. The guide covers the descriptive
pharmacological action of the therapeutics, its complete research and
development history and latest news and press releases.
The Juvenile Macular Degeneration (Ophthalmology) pipeline guide also
reviews of key players involved in therapeutic development for Juvenile
Macular Degeneration (Stargardt Disease) and features dormant and
discontinued projects. The guide covers therapeutics under Development by
Companies /Universities /Institutes, the molecules developed by Companies
in Phase II and Preclinical stages are 5 and 7 respectively. Similarly, the
Universities portfolio in Preclinical stages comprises 2 molecules,
respectively.
Juvenile Macular Degeneration (Ophthalmology) pipeline guide helps in
identifying and tracking emerging players in the market and their portfolios,
enhances decision making capabilities and helps to create effective counter
strategies to gain competitive advantage. The guide is built using data and
information sourced from Global Markets Directs proprietary databases,
company/university websites, clinical trial registries, conferences, SEC
filings, investor presentations and featured press releases from
company/university sites and industry-specific third party sources.
Additionally, various dynamic tracking processes ensure that the most recent
developments are captured on a real time basis.
Scope
- The pipeline guide provides a snapshot of the global therapeutic landscape of
Juvenile Macular Degeneration (Ophthalmology).
- The pipeline guide reviews pipeline therapeutics for Juvenile Macular
Degeneration (Ophthalmology) by companies and universities/research institutes
based on information derived from company and industry-specific sources.